| Name | Title | Contact Details |
|---|---|---|
Jena Pettit |
Director of Sales | Profile |
Spencer Bloxham |
Regional Vice President of Customer Engagement - West | Profile |
John deLorimier |
EVP, Customer Growth and Experience | Profile |
Thomas Devasia |
Senior VP & Chief Marketing & Innovation Officer | Profile |
Thomas Devasia |
Senior VP & Chief Marketing & Innovation Officer | Profile |
Arizona Spinal Cord Injury Association is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OneLegacy is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BDF is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
Health2047 Inc. is a Silicon Valley integrated innovation enterprise whose mission is to develop, guide, and commercialize disruptive ideas that enhance — at the system level— the practice of healthcare.